From the early 20th century discovery that cancer is a disease of the genome to having sequenced more than one million humans’ genomes today - this is just some of the history Amoolya Singh, Senior Vice President of Data Science and Chief Scientific Officer at GRAIL discusses when she shares the role of genomics and AI in cancer detection, what’s needed for population-scale screening tests, and what she’s excited about for the future.

Full transcript available at https://bit.ly/40T48FD

Sign up for GRAIL’s monthly newsletter: http://bit.ly/3lwlwjn